Role and implications of the CXCL12/CXCR4/CXCR7 axis in atherosclerosis: still a debate

Atherosclerosis is one of the leading causes of mortality and morbidity worldwide. Chemokines and their receptors are implicated in the pathogenesis of atherosclerosis. CXCL12 is a member of the chemokine family exerting a myriad role in atherosclerosis through its classical CXCR4 and atypical ACKR3...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of medicine (Helsinki) 2021-01, Vol.53 (1), p.1598-1612
Hauptverfasser: Murad, Hussam A. S., Rafeeq, Misbahuddin M., Alqurashi, Thamer M. A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1612
container_issue 1
container_start_page 1598
container_title Annals of medicine (Helsinki)
container_volume 53
creator Murad, Hussam A. S.
Rafeeq, Misbahuddin M.
Alqurashi, Thamer M. A.
description Atherosclerosis is one of the leading causes of mortality and morbidity worldwide. Chemokines and their receptors are implicated in the pathogenesis of atherosclerosis. CXCL12 is a member of the chemokine family exerting a myriad role in atherosclerosis through its classical CXCR4 and atypical ACKR3 (CXCR7) receptors. The modulatory and regulatory functional spectrum of CXCL12/CXCR4/ACKR3 axis in atherosclerosis spans from proatherogenic, prothrombotic and proinflammatory to atheroprotective, plaque stabilizer and dyslipidemia rectifier. This diverse continuum is executed in a wide range of biological units including endothelial cells (ECs), progenitor cells, macrophages, monocytes, platelets, lymphocytes, neutrophils and vascular smooth muscle cells (VSMCs) through complex heterogeneous and homogenous coupling of CXCR4 and ACKR3 receptors, employing different downstream signalling pathways, which often cross-talk among themselves and with other signalling interactomes. Hence, a better understanding of this structural and functional heterogeneity and complex phenomenon involving CXCL12/CXCR4/ACKR3 axis in atherosclerosis would not only help in formulation of novel therapeutics, but also in elucidation of the CXCL12 ligand and its receptors, as possible diagnostic and prognostic biomarkers. Key messages The role of CXCL12 per se is proatherogenic in atherosclerosis development and progression. The CXCL12 receptors, CXCR4 and ACKR3 perform both proatherogenic and athero-protective functions in various cell types Due to functional heterogeneity and cross talk of CXCR4 and ACKR3 at receptor level and downstream pathways, regional boosting with specific temporal and spatial modulators of CXCL12, CXCR4 and ACKR3 need to be explored.
doi_str_mv 10.1080/07853890.2021.1974084
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8439212</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_1a428290503143c4907b4deaa4fd2f6f</doaj_id><sourcerecordid>2570375806</sourcerecordid><originalsourceid>FETCH-LOGICAL-c534t-84656f4e5ddef1e52ec5ec75b7df11620ca39d7680861fb4b9957640609f35043</originalsourceid><addsrcrecordid>eNp9kV1rFDEUhgdR7Fr9CUouvZntydck44Uoix-FBaEoehcy-WhTMpM1mVX77810t8XeCOEcyHnPc07yNs1LDGsMEs5ASE5lD2sCBK9xLxhI9qhZYdrxlkAHj5vVomkX0UnzrJRrACACw9PmhDLW18NXzfeLFB3Sk0Vh3MVg9BzSVFDyaL5yaPNjs8XkrKYLdhsF0n9CQWFCutZzKiYuMZQ3qMwhRqSRdYOe3fPmidexuBfHfNp8-_jh6-Zzu_3y6XzzftsaTtncStbxzjPHrXUeO06c4c4IPgjrMe4IGE17KzoJssN-YEPfc9Gx-rzeUw6MnjbnB65N-lrtchh1vlFJB3V7kfKl0nkOdU2FNSOS9MCBYkYN60EMzDqtmbfEd76y3h5Yu_0wOmvcNGcdH0AfVqZwpS7TLyUZ7QkmFfD6CMjp596VWY2hGBejnlzaF0W4ACq4hK5K-UFq6veV7Pz9GAxqMVjdGawWg9XR4Nr36t8d77vuHK2CdwdBmHzKo_6dcrRq1jcxZZ_1ZEJR9P8z_gIZi7Lo</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2570375806</pqid></control><display><type>article</type><title>Role and implications of the CXCL12/CXCR4/CXCR7 axis in atherosclerosis: still a debate</title><source>Taylor &amp; Francis Open Access</source><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Murad, Hussam A. S. ; Rafeeq, Misbahuddin M. ; Alqurashi, Thamer M. A.</creator><creatorcontrib>Murad, Hussam A. S. ; Rafeeq, Misbahuddin M. ; Alqurashi, Thamer M. A.</creatorcontrib><description>Atherosclerosis is one of the leading causes of mortality and morbidity worldwide. Chemokines and their receptors are implicated in the pathogenesis of atherosclerosis. CXCL12 is a member of the chemokine family exerting a myriad role in atherosclerosis through its classical CXCR4 and atypical ACKR3 (CXCR7) receptors. The modulatory and regulatory functional spectrum of CXCL12/CXCR4/ACKR3 axis in atherosclerosis spans from proatherogenic, prothrombotic and proinflammatory to atheroprotective, plaque stabilizer and dyslipidemia rectifier. This diverse continuum is executed in a wide range of biological units including endothelial cells (ECs), progenitor cells, macrophages, monocytes, platelets, lymphocytes, neutrophils and vascular smooth muscle cells (VSMCs) through complex heterogeneous and homogenous coupling of CXCR4 and ACKR3 receptors, employing different downstream signalling pathways, which often cross-talk among themselves and with other signalling interactomes. Hence, a better understanding of this structural and functional heterogeneity and complex phenomenon involving CXCL12/CXCR4/ACKR3 axis in atherosclerosis would not only help in formulation of novel therapeutics, but also in elucidation of the CXCL12 ligand and its receptors, as possible diagnostic and prognostic biomarkers. Key messages The role of CXCL12 per se is proatherogenic in atherosclerosis development and progression. The CXCL12 receptors, CXCR4 and ACKR3 perform both proatherogenic and athero-protective functions in various cell types Due to functional heterogeneity and cross talk of CXCR4 and ACKR3 at receptor level and downstream pathways, regional boosting with specific temporal and spatial modulators of CXCL12, CXCR4 and ACKR3 need to be explored.</description><identifier>ISSN: 0785-3890</identifier><identifier>EISSN: 1365-2060</identifier><identifier>DOI: 10.1080/07853890.2021.1974084</identifier><identifier>PMID: 34494495</identifier><language>eng</language><publisher>England: Taylor &amp; Francis</publisher><subject>Atherosclerosis - blood ; Cardiology &amp; Cardiovascular Disorders ; Cardiovascular ; Chemokine CXCL12 ; dyslipidaemia ; Endothelial Cells ; Humans ; inflammation ; injury ; Receptors, CXCR ; Receptors, CXCR4 ; Review ; Signal Transduction ; thrombosis</subject><ispartof>Annals of medicine (Helsinki), 2021-01, Vol.53 (1), p.1598-1612</ispartof><rights>2021 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group 2021</rights><rights>2021 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group 2021 The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c534t-84656f4e5ddef1e52ec5ec75b7df11620ca39d7680861fb4b9957640609f35043</citedby><cites>FETCH-LOGICAL-c534t-84656f4e5ddef1e52ec5ec75b7df11620ca39d7680861fb4b9957640609f35043</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439212/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439212/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,2102,27502,27924,27925,53791,53793,59143,59144</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34494495$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Murad, Hussam A. S.</creatorcontrib><creatorcontrib>Rafeeq, Misbahuddin M.</creatorcontrib><creatorcontrib>Alqurashi, Thamer M. A.</creatorcontrib><title>Role and implications of the CXCL12/CXCR4/CXCR7 axis in atherosclerosis: still a debate</title><title>Annals of medicine (Helsinki)</title><addtitle>Ann Med</addtitle><description>Atherosclerosis is one of the leading causes of mortality and morbidity worldwide. Chemokines and their receptors are implicated in the pathogenesis of atherosclerosis. CXCL12 is a member of the chemokine family exerting a myriad role in atherosclerosis through its classical CXCR4 and atypical ACKR3 (CXCR7) receptors. The modulatory and regulatory functional spectrum of CXCL12/CXCR4/ACKR3 axis in atherosclerosis spans from proatherogenic, prothrombotic and proinflammatory to atheroprotective, plaque stabilizer and dyslipidemia rectifier. This diverse continuum is executed in a wide range of biological units including endothelial cells (ECs), progenitor cells, macrophages, monocytes, platelets, lymphocytes, neutrophils and vascular smooth muscle cells (VSMCs) through complex heterogeneous and homogenous coupling of CXCR4 and ACKR3 receptors, employing different downstream signalling pathways, which often cross-talk among themselves and with other signalling interactomes. Hence, a better understanding of this structural and functional heterogeneity and complex phenomenon involving CXCL12/CXCR4/ACKR3 axis in atherosclerosis would not only help in formulation of novel therapeutics, but also in elucidation of the CXCL12 ligand and its receptors, as possible diagnostic and prognostic biomarkers. Key messages The role of CXCL12 per se is proatherogenic in atherosclerosis development and progression. The CXCL12 receptors, CXCR4 and ACKR3 perform both proatherogenic and athero-protective functions in various cell types Due to functional heterogeneity and cross talk of CXCR4 and ACKR3 at receptor level and downstream pathways, regional boosting with specific temporal and spatial modulators of CXCL12, CXCR4 and ACKR3 need to be explored.</description><subject>Atherosclerosis - blood</subject><subject>Cardiology &amp; Cardiovascular Disorders</subject><subject>Cardiovascular</subject><subject>Chemokine CXCL12</subject><subject>dyslipidaemia</subject><subject>Endothelial Cells</subject><subject>Humans</subject><subject>inflammation</subject><subject>injury</subject><subject>Receptors, CXCR</subject><subject>Receptors, CXCR4</subject><subject>Review</subject><subject>Signal Transduction</subject><subject>thrombosis</subject><issn>0785-3890</issn><issn>1365-2060</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>0YH</sourceid><sourceid>EIF</sourceid><sourceid>DOA</sourceid><recordid>eNp9kV1rFDEUhgdR7Fr9CUouvZntydck44Uoix-FBaEoehcy-WhTMpM1mVX77810t8XeCOEcyHnPc07yNs1LDGsMEs5ASE5lD2sCBK9xLxhI9qhZYdrxlkAHj5vVomkX0UnzrJRrACACw9PmhDLW18NXzfeLFB3Sk0Vh3MVg9BzSVFDyaL5yaPNjs8XkrKYLdhsF0n9CQWFCutZzKiYuMZQ3qMwhRqSRdYOe3fPmidexuBfHfNp8-_jh6-Zzu_3y6XzzftsaTtncStbxzjPHrXUeO06c4c4IPgjrMe4IGE17KzoJssN-YEPfc9Gx-rzeUw6MnjbnB65N-lrtchh1vlFJB3V7kfKl0nkOdU2FNSOS9MCBYkYN60EMzDqtmbfEd76y3h5Yu_0wOmvcNGcdH0AfVqZwpS7TLyUZ7QkmFfD6CMjp596VWY2hGBejnlzaF0W4ACq4hK5K-UFq6veV7Pz9GAxqMVjdGawWg9XR4Nr36t8d77vuHK2CdwdBmHzKo_6dcrRq1jcxZZ_1ZEJR9P8z_gIZi7Lo</recordid><startdate>20210101</startdate><enddate>20210101</enddate><creator>Murad, Hussam A. S.</creator><creator>Rafeeq, Misbahuddin M.</creator><creator>Alqurashi, Thamer M. A.</creator><general>Taylor &amp; Francis</general><general>Taylor &amp; Francis Group</general><scope>0YH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20210101</creationdate><title>Role and implications of the CXCL12/CXCR4/CXCR7 axis in atherosclerosis: still a debate</title><author>Murad, Hussam A. S. ; Rafeeq, Misbahuddin M. ; Alqurashi, Thamer M. A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c534t-84656f4e5ddef1e52ec5ec75b7df11620ca39d7680861fb4b9957640609f35043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Atherosclerosis - blood</topic><topic>Cardiology &amp; Cardiovascular Disorders</topic><topic>Cardiovascular</topic><topic>Chemokine CXCL12</topic><topic>dyslipidaemia</topic><topic>Endothelial Cells</topic><topic>Humans</topic><topic>inflammation</topic><topic>injury</topic><topic>Receptors, CXCR</topic><topic>Receptors, CXCR4</topic><topic>Review</topic><topic>Signal Transduction</topic><topic>thrombosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Murad, Hussam A. S.</creatorcontrib><creatorcontrib>Rafeeq, Misbahuddin M.</creatorcontrib><creatorcontrib>Alqurashi, Thamer M. A.</creatorcontrib><collection>Taylor &amp; Francis Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Annals of medicine (Helsinki)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Murad, Hussam A. S.</au><au>Rafeeq, Misbahuddin M.</au><au>Alqurashi, Thamer M. A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role and implications of the CXCL12/CXCR4/CXCR7 axis in atherosclerosis: still a debate</atitle><jtitle>Annals of medicine (Helsinki)</jtitle><addtitle>Ann Med</addtitle><date>2021-01-01</date><risdate>2021</risdate><volume>53</volume><issue>1</issue><spage>1598</spage><epage>1612</epage><pages>1598-1612</pages><issn>0785-3890</issn><eissn>1365-2060</eissn><abstract>Atherosclerosis is one of the leading causes of mortality and morbidity worldwide. Chemokines and their receptors are implicated in the pathogenesis of atherosclerosis. CXCL12 is a member of the chemokine family exerting a myriad role in atherosclerosis through its classical CXCR4 and atypical ACKR3 (CXCR7) receptors. The modulatory and regulatory functional spectrum of CXCL12/CXCR4/ACKR3 axis in atherosclerosis spans from proatherogenic, prothrombotic and proinflammatory to atheroprotective, plaque stabilizer and dyslipidemia rectifier. This diverse continuum is executed in a wide range of biological units including endothelial cells (ECs), progenitor cells, macrophages, monocytes, platelets, lymphocytes, neutrophils and vascular smooth muscle cells (VSMCs) through complex heterogeneous and homogenous coupling of CXCR4 and ACKR3 receptors, employing different downstream signalling pathways, which often cross-talk among themselves and with other signalling interactomes. Hence, a better understanding of this structural and functional heterogeneity and complex phenomenon involving CXCL12/CXCR4/ACKR3 axis in atherosclerosis would not only help in formulation of novel therapeutics, but also in elucidation of the CXCL12 ligand and its receptors, as possible diagnostic and prognostic biomarkers. Key messages The role of CXCL12 per se is proatherogenic in atherosclerosis development and progression. The CXCL12 receptors, CXCR4 and ACKR3 perform both proatherogenic and athero-protective functions in various cell types Due to functional heterogeneity and cross talk of CXCR4 and ACKR3 at receptor level and downstream pathways, regional boosting with specific temporal and spatial modulators of CXCL12, CXCR4 and ACKR3 need to be explored.</abstract><cop>England</cop><pub>Taylor &amp; Francis</pub><pmid>34494495</pmid><doi>10.1080/07853890.2021.1974084</doi><tpages>15</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0785-3890
ispartof Annals of medicine (Helsinki), 2021-01, Vol.53 (1), p.1598-1612
issn 0785-3890
1365-2060
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8439212
source Taylor & Francis Open Access; MEDLINE; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Atherosclerosis - blood
Cardiology & Cardiovascular Disorders
Cardiovascular
Chemokine CXCL12
dyslipidaemia
Endothelial Cells
Humans
inflammation
injury
Receptors, CXCR
Receptors, CXCR4
Review
Signal Transduction
thrombosis
title Role and implications of the CXCL12/CXCR4/CXCR7 axis in atherosclerosis: still a debate
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T13%3A12%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20and%20implications%20of%20the%20CXCL12/CXCR4/CXCR7%20axis%20in%20atherosclerosis:%20still%20a%20debate&rft.jtitle=Annals%20of%20medicine%20(Helsinki)&rft.au=Murad,%20Hussam%20A.%20S.&rft.date=2021-01-01&rft.volume=53&rft.issue=1&rft.spage=1598&rft.epage=1612&rft.pages=1598-1612&rft.issn=0785-3890&rft.eissn=1365-2060&rft_id=info:doi/10.1080/07853890.2021.1974084&rft_dat=%3Cproquest_pubme%3E2570375806%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2570375806&rft_id=info:pmid/34494495&rft_doaj_id=oai_doaj_org_article_1a428290503143c4907b4deaa4fd2f6f&rfr_iscdi=true